Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BHVN | WHR |
|---|---|---|
| Price | $12.97 | $30.03 |
| Change today | ▲ 0.78% | ▼ 0.92% |
| Market cap | $1.96B | $1.96B |
| Return, 3 months | -16.6% | -19.1% |
| Return, year to date | +14.9% | -57.8% |
| Return, 1 year | -18.3% | -61.1% |
| P/E (TTM) | -2.9 | 9.9 |
| P/B | 160.1 | 0.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 8.99% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +61.9% | +33.7% |
| Analyst buy share | 70% | 0% |
| RSI (14) | 44 | 27 |
| 30-day volatility | 93.7% | 38.1% |
| Max drawdown, 1 year | -57.0% | -67.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
